| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology and Genetics |
1 Department of Biochemistry, College of Medicine, Ewha Women's University; 2 Molecular Therapy Research Center and 3 Department of Thoracic Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Ilwon-dong, Kangnam-ku, Seoul, Korea; and 4 Department of Cell Biology, The University of Alabama at Birmingham, Birmingham, Alabama
Requests for reprints: Kyoungsook Park, Molecular Therapy Research Center, Sungkyunkwan University, Samsung Medical Center, Annex 8F, 50 Ilwon-dong, Kangnam-ku, 135-710 Seoul, Korea. Phone: 82-2-3410-3638; Fax: 82-2-3410-3649; E-mail: hannah05{at}dreamwiz.com.
Bcl-2 is involved in the progression of human malignancies, but the precise role and mechanism of Bcl-2 for tumor invasion and metastasis remains unclear. In this study, we have investigated the role and mechanism of Bcl-2 on tumor cell invasion and metastasis by using Bcl-2 overexpressing non–small cell lung cancer cells. Matrix metalloproteinases (MMPs) are important proteins involved in the processes of tumor invasion and metastasis. In vitro Matrigel invasion assays showed that Bcl-2 overexpression increased tumor cell invasion by 15-fold. Moreover, Bcl-2 overexpression enhanced in vivo lung metastasis by 4-fold. Consistent with its effect on invasion and metastasis, Bcl-2 overexpression induced not only MMP-2 mRNA and its protein expression, but this also activated the pro-MMP-2 protein to its active form. To explore the induction mechanism of MMP-2 by Bcl-2, we investigated the effects of Bcl-2 overexpression on MMP-2 transcriptional regulation. Nuclear run-on assays showed a 6-fold increase in the transcription rate of MMP-2 mRNA in the Bcl-2 transfectants (H157/Bcl-2) compared with that of the H157/vector control cells (H157/C). Overexpression of Bcl-2 induced the nuclear transcription factor activator protein 1 family, including the c-Jun, JunD, c-Fos, FosB, and Fra-1 proteins. Reporter assays combined with deletion mutagenesis analysis and gel shift assays showed the involvement of activator protein 1 in the activation of MMP-2 promoter activity by Bcl-2. Taken together, we have shown that Bcl-2 promotes tumor invasion and lung metastasis by inducing MMP-2 gene expression through the combined action of transcriptional and posttranslational mechanisms.
This article has been cited by other articles:
|
|
 |
|
  X. Wang, K. Belguise, C. F. O'Neill, N. Sanchez-Morgan, M. Romagnoli, S. F. Eddy, N. D. Mineva, Z. Yu, C. Min, V. Trinkaus-Randall, et al. RelB NF-{kappa}B Represses Estrogen Receptor {alpha} Expression via Induction of the Zinc Finger Protein Blimp1 Mol. Cell. Biol., July 15, 2009; 29(14): 3832 - 3844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-W. HUANG, L.-S. WANG, M. K. DOWD, P. J. WAN, and Y. C. LIN (-)-Gossypol Reduces Invasiveness in Metastatic Prostate Cancer Cells Anticancer Res, June 1, 2009; 29(6): 2179 - 2188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sasi, M. Hwang, J. Jaboin, I. Csiki, and B. Lu Regulated cell death pathways: New twists in modulation of BCL2 family function Mol. Cancer Ther., June 1, 2009; 8(6): 1421 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Zeitlin, I. J. Zeitlin, and J. E. Nor Expanding Circle of Inhibition: Small-Molecule Inhibitors of Bcl-2 as Anticancer Cell and Antiangiogenic Agents J. Clin. Oncol., September 1, 2008; 26(25): 4180 - 4188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. F. Tumilasci, S. Oliere, T. L.-A. Nguyen, A. Shamy, J. Bell, and J. Hiscott Targeting the Apoptotic Pathway with BCL-2 Inhibitors Sensitizes Primary Chronic Lymphocytic Leukemia Cells to Vesicular Stomatitis Virus-Induced Oncolysis J. Virol., September 1, 2008; 82(17): 8487 - 8499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kong, Z. Wang, S. H. Sarkar, Y. Li, S. Banerjee, A. Saliganan, H.-R. C. Kim, M. L. Cher, and F. H. Sarkar Platelet-Derived Growth Factor-D Overexpression Contributes to Epithelial-Mesenchymal Transition of PC3 Prostate Cancer Cells Stem Cells, June 1, 2008; 26(6): 1425 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Baraldo, E. Bazzan, M. E. Zanin, G. Turato, S. Garbisa, P. Maestrelli, A. Papi, M. Miniati, L. M. Fabbri, R. Zuin, et al. Matrix Metalloproteinase-2 Protein in Lung Periphery Is Related to COPD Progression Chest, December 1, 2007; 132(6): 1733 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Greenlee, Z. Werb, and F. Kheradmand Matrix Metalloproteinases in Lung: Multiple, Multifarious, and Multifaceted Physiol Rev, January 1, 2007; 87(1): 69 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Manjarrez, R. Ocadiz, L. Valle, C. Pacheco, A. Marroquin, C. De la Torre, M. Selman, and P. Gariglio Detection of Human Papillomavirus and Relevant Tumor Suppressors and Oncoproteins in Laryngeal Tumors Clin. Cancer Res., December 1, 2006; 12(23): 6946 - 6951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. H. Bae, M.-J. Park, S. H. Yoon, S. W. Kang, S.-S. Lee, K.-M. Choi, and H.-D. Um Bcl-w Promotes Gastric Cancer Cell Invasion by Inducing Matrix Metalloproteinase-2 Expression via Phosphoinositide 3-Kinase, Akt, and Sp1. Cancer Res., May 15, 2006; 66(10): 4991 - 4995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Promotion of Invasion and Metastatic Potential by Bcl-2 Cancer Res., January 15, 2006; 66(2): 1250 - 1250. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
